Calmerry vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 36)
Calmerry logo

Calmerry

EmergingMental Health Tech

Online Therapy Platform

Subscription online therapy via text, video, and audio; accessible pricing for patients managing anxiety and depression; therapist matching with easy switching based on preference selection.

AI VisibilityBeta
Overall Score
D36
Category Rank
#507 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
36
Gemini
39

About

Calmerry is an online therapy platform that connects individuals with licensed therapists for mental health support through a subscription model covering text messaging, live video sessions, and audio calls. The platform focuses on accessibility and affordability, offering therapy to users who face barriers of cost, stigma, or geographic access to traditional in-person care. Calmerry matches clients to therapists based on their presenting concerns, preferences, and therapist specialization, with the ability to switch therapists if the initial match is not a good fit. The platform serves a primarily direct-to-consumer audience, individuals managing anxiety, depression, relationship issues, stress, and other mental health concerns. Calmerry competes with BetterHelp and Talkspace in the online therapy market, differentiating through competitive pricing and a straightforward subscription structure. The company has grown rapidly as awareness of teletherapy has expanded following the COVID-19 pandemic, which accelerated consumer acceptance of remote mental healthcare.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

36
Overall Score
88
#507
Category Rank
#3
83
AI Consensus
78
stable
Trend
stable
35
ChatGPT
83
36
Perplexity
87
39
Gemini
85
33
Claude
90
32
Grok
92

Key Details

Category
Online Therapy Platform
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Calmerry
Online Therapy Platform
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.